000 01490 a2200421 4500
005 20250515025214.0
264 0 _c20060804
008 200608s 0 0 eng d
022 _a1172-7047
024 7 _a10.2165/00023210-200620050-00006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMoen, Marit D
245 0 0 _aZolpidem extended-release.
_h[electronic resource]
260 _bCNS drugs
_c2006
300 _a419-26; discussion 427-8 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aDelayed-Action Preparations
_xadministration & dosage
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypnotics and Sedatives
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPolysomnography
650 0 4 _aPractice Guidelines as Topic
650 0 4 _aPyridines
_xadministration & dosage
650 0 4 _aSleep
_xdrug effects
650 0 4 _aSleep Initiation and Maintenance Disorders
_xdrug therapy
650 0 4 _aZolpidem
700 1 _aPlosker, Greg L
773 0 _tCNS drugs
_gvol. 20
_gno. 5
_gp. 419-26; discussion 427-8
856 4 0 _uhttps://doi.org/10.2165/00023210-200620050-00006
_zAvailable from publisher's website
999 _c16296695
_d16296695